<bill session="117" type="s" number="4071" updated="2022-12-29T23:48:36Z">
  <state datetime="2022-04-07">REFERRED</state>
  <status>
    <introduced datetime="2022-04-07"/>
  </status>
  <introduced datetime="2022-04-07"/>
  <titles>
    <title type="display">Helping Experts Accelerate Rare Treatments Act of 2022</title>
    <title type="short" as="introduced">Helping Experts Accelerate Rare Treatments Act of 2022</title>
    <title type="official" as="introduced">A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the treatment of rare diseases and conditions, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="C001070"/>
  <cosponsors>
    <cosponsor bioguide_id="S001184" joined="2022-04-07"/>
  </cosponsors>
  <actions>
    <action datetime="2022-04-07">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2022-04-07" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2022-10-18T14:49:56Z" status="Introduced in Senate">Helping Experts Accelerate Rare Treatments Act of 2022

This bill modifies provisions relating to the approval of drugs for rare diseases and conditions, including by requiring regular reporting on the number and types of applications received and the extent to which external experts are consulted during the review process.</summary>
</bill>
